Structured Gaussian Processes for Uncertainty-Aware Classification of High-Dimensional, Small-Sampled Omics Data
Using biological networks to predict disease from genetic data with few samples
Researchers developed a new machine-learning method that predicts disease states from genetic data by incorporating known biological pathways directly into its decision-making process. The approach outperformed standard methods on microbiome datasets and naturally flags uncertain predictions, which is crucial when working with small sample sizes where confidence matters as much as accuracy.
Most genetic disease prediction fails in real clinical settings because training data is scarce and imbalanced—healthy people vastly outnumber sick ones. This method addresses both problems by leveraging what we already know about how genes interact, meaning hospitals could make more reliable predictions from smaller patient groups. The built-in confidence scores also help clinicians avoid false alarms and know when a result is unreliable.